Alnylam Pharmaceuticals Inc (ALNY)
246.80
-1.99
(-0.80%)
USD |
NASDAQ |
Nov 21, 16:00
249.68
+2.88
(+1.17%)
After-Hours: 20:00
Alnylam Pharmaceuticals Profit Margin (Quarterly): -22.27% for Sept. 30, 2024
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | -22.27% |
| June 30, 2024 | -2.56% |
| March 31, 2024 | -13.34% |
| December 31, 2023 | -31.35% |
| September 30, 2023 | 19.69% |
| June 30, 2023 | -86.59% |
| March 31, 2023 | -54.53% |
| December 31, 2022 | -61.93% |
| September 30, 2022 | -153.6% |
| June 30, 2022 | -123.4% |
| March 31, 2022 | -112.7% |
| December 31, 2021 | -99.97% |
| September 30, 2021 | -109.0% |
| June 30, 2021 | -85.95% |
| March 31, 2021 | -112.8% |
| December 31, 2020 | -148.9% |
| September 30, 2020 | -201.3% |
| June 30, 2020 | -172.4% |
| March 31, 2020 | -183.2% |
| December 31, 2019 | -385.3% |
| September 30, 2019 | -297.6% |
| June 30, 2019 | -490.9% |
| March 31, 2019 | -546.4% |
| December 31, 2018 | -1.01K% |
| September 30, 2018 | -11.86K% |
| Date | Value |
|---|---|
| June 30, 2018 | -546.9% |
| March 31, 2018 | -644.8% |
| December 31, 2017 | -375.0% |
| September 30, 2017 | -719.1% |
| June 30, 2017 | -743.3% |
| March 31, 2017 | -565.9% |
| December 31, 2016 | -647.0% |
| September 30, 2016 | -762.4% |
| June 30, 2016 | -1.03K% |
| March 31, 2016 | -1.40K% |
| December 31, 2015 | -1.20K% |
| September 30, 2015 | -1.21K% |
| June 30, 2015 | -826.5% |
| March 31, 2015 | -273.9% |
| December 31, 2014 | -89.05% |
| September 30, 2014 | -400.9% |
| June 30, 2014 | -604.2% |
| March 31, 2014 | -3.03K% |
| December 31, 2013 | -298.3% |
| September 30, 2013 | -330.2% |
| June 30, 2013 | -209.2% |
| March 31, 2013 | -48.35% |
| December 31, 2012 | -732.1% |
| September 30, 2012 | -116.4% |
| June 30, 2012 | -62.04% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-385.3%
Minimum
Dec 2019
19.69%
Maximum
Sep 2023
-107.1%
Average
-104.5%
Median
Profit Margin (Quarterly) Benchmarks
| Pfizer Inc | 25.22% |
| BridgeBio Pharma Inc | -5.93K% |
| Gilead Sciences Inc | 16.61% |
| Johnson & Johnson | 11.99% |
| Regeneron Pharmaceuticals Inc | 36.03% |
Profit Margin (Quarterly) Related Metrics
| Return on Assets | -8.43% |
| Return on Invested Capital | -36.66% |
| Gross Profit Margin (Quarterly) | 82.85% |
| Operating Margin (Quarterly) | -15.35% |
| Return on Net Operating Assets | -29.30% |